Arya Sciences Acquisition Corp. II (ARYB) Shareholders Approve Cerevel Deal
Arya Sciences Acquisition Corp. II (NYSE:ARYB) announced in an 8-K filing that it has secured shareholder approval for its business combination with biotech company Crevel Therapeutics in a vote held earlier today. ...READ MORE
